Cargando…
From infection niche to therapeutic target: the intracellular lifestyle of Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb) is an obligate human pathogen killing millions of people annually. Treatment for tuberculosis is lengthy and complicated, involving multiple drugs and often resulting in serious side effects and non-compliance. Mtb has developed numerous complex mechanisms enabling i...
Autores principales: | Rankine-Wilson, Leah Isobella, Shapira, Tirosh, Sao Emani, Carine, Av-Gay, Yossef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289223/ https://www.ncbi.nlm.nih.gov/pubmed/33826491 http://dx.doi.org/10.1099/mic.0.001041 |
Ejemplares similares
-
High-Content Screening of Eukaryotic Kinase Inhibitors Identify CHK2 Inhibitor Activity Against Mycobacterium tuberculosis
por: Shapira, Tirosh, et al.
Publicado: (2020) -
DMN-Tre Labeling for Detection and
High-Content Screening of Compounds against Intracellular Mycobacteria
por: Sahile, Henok A., et al.
Publicado: (2020) -
Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis
por: Richter, Adrian, et al.
Publicado: (2021) -
Hit Compounds and Associated Targets in Intracellular Mycobacterium tuberculosis
por: Tsui, Clement K. M., et al.
Publicado: (2022) -
Nitazoxanide Stimulates Autophagy and Inhibits mTORC1 Signaling and Intracellular Proliferation of Mycobacterium tuberculosis
por: Lam, Karen K. Y., et al.
Publicado: (2012)